Table 2
Neutrophil count, erythrocyte sedimentation rate, and acute phase reactants (α1 antitrypsin, α2 macroglobulin) in patients with active or inactive Behçet's disease and controls
| Active BD (n=20) | Inactive BD (n=23) | Healthy controls (n=25) | |
|---|---|---|---|
| Mean (SD) | Mean (SD) | Mean (SD) | |
| ESR, erythrocyte sedimentation rate. | |||
| †Significantly different from the inactive stage by Wilcoxon test (for each, p<0.01). | |||
| ‡Significantly different from the controls by Mann-Whitney U test (for each, p<0.01). | |||
| Neutrophils (103/ml) | 5.64 (1.41)†‡ | 3.63 (0.78)‡ | 2.81 (0.41) |
| ESR (mm/h) | 32.88 (8.36)†‡ | 18.26 (6.15)‡ | 7.48 (1.85) |
| α1 antitrypsin (mg/dl) | 219.34 (39.42)†‡ | 163.19 (20.42)‡ | 121.64 (14.15) |
| α2 macroglobulin (mg/dl) | 269.52 (31.58)†‡ | 201.89 (28.54)‡ | 165.11 (23.91) |
